悦康药业：控股股东京悦永顺所持约3610万股公司股份解除司法冻结

Group 1 - The core point of the news is that Yuekang Pharmaceutical has had a significant portion of its shares released from judicial freeze, which may positively impact its stock performance and investor confidence [1] - As of the announcement date, the controlling shareholder, Jingyue Yongshun, holds a total of 153,740,120 shares in the company, with 5,670,654 shares still frozen [1] - The revenue composition for Yuekang Pharmaceutical for the year 2024 is as follows: 96.19% from pharmaceutical manufacturing, 3.46% from pharmaceutical agency, and 0.36% from other businesses [1] Group 2 - The current market capitalization of Yuekang Pharmaceutical is 14.5 billion yuan [2]